US FDA Updates Tobacco Product Registration and Listing Form: What Manufacturers Need to Know in 2026

The US FDA tobacco product registration and listing requirements remain an important compliance consideration for manufacturers operating in the United States. On September 29, 2026, the U.S. Food and Drug Administration (FDA) announced an updated Form FDA 3741 designed to simplify establishment registration and product listing submissions for regulated tobacco products.

The redesigned form consolidates previously separate forms into a single form covering multiple regulated tobacco product categories, including cigarettes, electronic cigarettes, smokeless tobacco, heated tobacco products and oral nicotine products such as nicotine pouches.

The update is intended to make the submission process more efficient and help manufacturers complete the sections relevant to their businesses. It does not remove the underlying registration and product listing obligations that apply to manufacturers under the relevant requirements.

What Has Changed in the FDA Registration Process?

Previously, manufacturers used different forms depending on the type of tobacco product involved. The redesigned Form FDA 3741 brings these categories together into one form.

According to the FDA, the updated form includes a submission checklist that guides applicants through the relevant sections. It also allows existing registrants to update certain information without resubmitting unchanged sections.

Key changes include:

• One consolidated form: Form FDA 3741 covers multiple regulated tobacco product categories.
• A guided submission checklist: Manufacturers can identify the sections relevant to their submissions.
• Targeted updates: Certain existing registration information can be updated without resubmitting unchanged information.
• Electronic submission: The FDA encourages establishments to use the Tobacco Registration and Listing Module Next Generation (TRLM NG) system.

These changes relate to the administrative submission process. Companies should continue to follow the FDA’s current instructions when preparing their records and submissions.

Official source: FDA Updates Tobacco Product Establishment Registration and Product Listing Form.

Which Tobacco Product Categories Are Covered?

The redesigned form covers multiple regulated tobacco product categories, including:

Cigarettes and Smokeless Tobacco

Manufacturers of cigarettes and relevant smokeless tobacco products should review the applicable registration and product listing instructions and maintain accurate establishment and product information.

Electronic Nicotine Delivery Systems

Businesses manufacturing regulated electronic cigarettes and related products should review the current FDA requirements for establishment registration and product listing. These obligations are distinct from the premarket authorisation requirements that may apply to individual products.

Heated Tobacco Products

Manufacturers of regulated heated tobacco products should verify that their establishment and product information is accurate and that submissions follow the applicable FDA procedures.

Oral Nicotine Products and Nicotine Pouches

Companies involved in oral nicotine products, including nicotine pouches, should check the current regulatory classification and requirements applicable to their products and activities.

Coverage under a registration form does not, by itself, mean that a product has received FDA marketing authorisation.

Important Registration and Product Listing Deadlines

The FDA’s September 2026 announcement describes the following recurring deadlines for domestic tobacco product manufacturers subject to these requirements:

• December 31: Annual establishment registration.
• June 30 and December 31: Product listing submissions when certain changes have occurred.

These dates should not be interpreted as requiring every manufacturer to submit a completely new product listing twice each year regardless of circumstances. The applicable obligations depend on the requirements and whether relevant changes have occurred.

Manufacturers should consult the FDA’s official instructions and confirm their individual responsibilities rather than relying solely on a general summary.

What Should Manufacturers Do Now?

Companies can take several practical steps to prepare for registration and product listing submissions.

1. Review Existing Establishment Information

Check establishment details, contact information and other required records for accuracy. Identify any information that needs updating before the relevant submission deadline.

2. Verify Product Listing Records

Review the products associated with the establishment and identify changes that may trigger a listing update under applicable FDA requirements.

3. Use the Current Form and Submission System

The FDA has retired the previous versions of Forms FDA 3741 and 3741a. Manufacturers should follow the current instructions for the redesigned form and the TRLM NG electronic submission system.

4. Maintain Controlled Documentation

Keep records of product information, submission dates, updates and supporting documentation. Assign responsibility for reviewing changes and maintaining accurate records.

5. Coordinate Regulatory and Quality Teams

Regulatory affairs, quality assurance, manufacturing and management teams should communicate when relevant establishment or product information changes. Clear internal responsibilities can help reduce errors and missed updates.

These are general operational recommendations. Companies should determine which specific records and submission steps apply to their circumstances.

Registration Is Not the Same as FDA Product Authorisation

One important distinction is the difference between establishment registration, product listing and premarket marketing authorisation.

Establishment registration identifies relevant manufacturing establishments under the applicable FDA requirements.

Product listing provides information about tobacco products as required by the applicable rules.

Premarket authorisation is a separate regulatory process that may be required before a new tobacco product can legally be marketed in the United States.

For certain new tobacco products, the Premarket Tobacco Product Application (PMTA) pathway requires scientific information that enables the FDA to assess whether marketing the product would be appropriate for the protection of public health.

Submitting a registration or listing form does not automatically authorise a product for sale. Businesses should verify the specific regulatory status of each relevant product.

For further information, consult the FDA’s official Premarket Tobacco Product Applications resource.

What Does This Mean for International Suppliers?

International suppliers considering business relationships connected to the US tobacco market should understand the distinction between supplying ingredients and manufacturing or marketing finished tobacco products.

The redesigned registration form does not automatically establish that an overseas ingredient supplier must complete the same submissions as a domestic tobacco product manufacturer. Responsibilities depend on the business activity, regulatory status, product and applicable law.

Before entering a supply arrangement, companies should clarify the roles of the supplier, manufacturer, importer and other relevant parties. They should also confirm which product specifications, technical records and compliance documents their customers require.

For background on nicotine ingredient information and procurement documentation, see McCoy NIC’s nicotine procurement information. This is a company resource, not evidence of FDA approval or authorisation.